Opinion editor's note: Editorials represent the opinions of the Star Tribune Editorial Board, which operates independently from the newsroom.
•••
Catherine Mayberry was an honor student at Minnetonka High School. An award-winning artist. A varsity tennis player who also loved skiing and softball. A loving sister and daughter.
On Oct. 8, at age 24, she died from an accidental overdose of meth mixed with fentanyl. Sadly, her parents, Trent and Jane Mayberry, consider this her "second death."
In their view, they'd already lost her after she began using marijuana heavily in her late teens. As Catherine's mental health relentlessly deteriorated, the family discovered that a drug that many think is harmless in reality poses substantial risks for some users. Catherine was among those who develop psychosis after using the drug. She suffered from auditory hallucinations, delusional thinking, extreme anxiety and slowed mental capacity that permanently derailed her promising young life.
"This is what our family now refers to as 'Catherine's first death,'" Trent Mayberry said in recent testimony before the Minnesota Legislature.
It would be far easier for the family to grieve quietly than to share their pain. But with the state lawmakers on track to legalize adult-use recreational marijuana, the heartbroken couple is sharing their story to sound the alarm about a cannabis risk — the research-backed association between the drug and psychosis — that they only learned about as Catherine's life spiraled out of control.
The family's tragedy should not only inform the ongoing legalization debate but spur legislators to take steps to make the risks clear on cannabis packaging and to provide resources for those afflicted. It should also galvanize preparations within the state's medical community to better recognize this relatively rare but life-upending condition in cannabis users.